A non-automated, x-ray beam-limiting device that is a component of a therapeutic x-ray system and whose opening size/length/shutter assembly is fixed. It is used in radiation therapy applications to limit the effects of scattered radiation and to protect the p
| Company | Devices | Share |
|---|---|---|
| Aktina Corp. | 76 | 97% |
| Varian Medical Systems, Inc. | 2 | 3% |
Company = labeler of record on GUDID. 2 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| IYE | Accelerator, Linear, Medical | 76 |
| IYE | Accelerator, linear, medical | 2 |
Use these as the dimensions to specify in a tender line.
No closely related category with 50+ devices.
78 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Fixed-aperture therapeutic x-ray system collimator", from 2 companies. The largest labeler is Aktina Corp. with 97% of records.
IYE (Accelerator, Linear, Medical), IYE (Accelerator, linear, medical)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add fixed-aperture therapeutic x-ray system collimator to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.